CHRN NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

ChronoScale Corporation · Technology · Information Technology Services

Open interactive chart View report data
Latest close 22.03 USD
2.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 54.3% above the Trend Line and sits at 70.6% of its 52-week range. The latest completed week returned 2.5%, after a 33.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal.

Setup score 65 out of 100
Latest Close 22.03 USD 31 Jul 2026
1W Return 2.5% latest completed week
4W Return 33.6% short-term follow-through
12W Return 41.5% quarterly tape
Trend Breadth 69.2% 36 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • The trend backdrop is active with a 36-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.5% Latest completed week; four-week move 33.6%. Indicator stack 83/62 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.17% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 26 relevant articles in the latest sentiment read. Event risk 27 Jul Latest stored earnings date was 27 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 54.3% above the Trend Line and sits at 70.6% of its 52-week range. The latest completed week returned 2.5%, after a 33.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9412-week average 0.87

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.94Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 33.6% over four weeks, 41.5% over 12 weeks, and 531.2% over one year. The current trend has remained active for 36 consecutive weeks.

Performance by holding period

1W2.5%
4W33.6%
12W41.5%
26W153.2%
52W531.2%
Active trend streak36 weeks
Active weeks in one year36
Trend breadth69.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.79Latest activity-pressure read.
Pressure change-27.3%Four-week change in activity pressure.
Leadership105.45Latest relative-leadership reading.
RS change50.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Nov 2025 Field coverage 76% Model confidence 58%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength67/100Blend of value, momentum, and quality. Underlying universe rank 34; rank 1 is best.
Value58/100Relative valuation strength. Underlying universe rank 43; rank 1 is best.
Quality56/100Profitability and accounting quality. Underlying universe rank 45; rank 1 is best.
Momentum58/100Medium-term price momentum. Underlying universe rank 43; rank 1 is best.
Growth58/100Revenue and earnings growth. Underlying universe rank 43; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
37.0x
Market value relative to trailing revenue.
EV / EBITDA
123.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-36.7%
Gross profit retained from each unit of revenue.
Operating margin
-68.3%
Operating profit retained from revenue.
Free-cash-flow margin
-6.9%
Free cash flow generated from revenue.
Return on invested capital
-39.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 26 relevant articles.

2 positive · 24 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings27 JulLatest stored earnings date was 27 Jul 2026.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-26.6%Distance below the 52-week high.
13-week volatility18.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+32.1%Week of 8 May.
Worst week-25.8%Week of 3 Jul.
Latest week+2.5%Week of 31 Jul.

Shape of recent returns

Strong gains11
Modest gains4
Flat weeks0
Modest losses2
Sharp losses9
Recent vol18.1%13-week weekly-return volatility.
Base vol13.4%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew13.2% / -8.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape64/100

Trend, activity pressure, participation, and risk combine to a 64/100 tape read.

 Indicator analysis91/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.94; No reversal markers Next-Week ExpectancyPositive 55.17%

Next-week expectancy is positive with a 55.17% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors59/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 47; Small Cap Core rank 49 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 26 relevant articles.

CHRN Price Today: ChronoScale Holdings Corporation Stock Price, Quote & Chart | MEXC Insiders50/100

No recent insider transaction evidence is stored.

 Earnings27 Jul

Latest stored earnings date was 27 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202622.03 USD2.5%14.28 USD13.30 USD0.79105.45918.9KOn
24 Jul 202621.50 USD-18.7%13.81 USD13.27 USD0.82108.221.4MOn
17 Jul 202626.43 USD26.5%13.27 USD13.25 USD1.05159.442.4MOn
10 Jul 202620.90 USD26.7%12.56 USD13.20 USD1.03105.021.6MOn
3 Jul 202616.49 USD-25.8%12.01 USD13.19 USD1.0969.971.8MOn
26 Jun 202622.23 USD-4.7%11.61 USD13.21 USD1.31136.872.3MOn
19 Jun 202623.33 USD27.1%11.02 USD13.21 USD1.24146.441.4MOn
12 Jun 202618.36 USD-3.5%10.38 USD13.19 USD1.09107.241.9MOn
5 Jun 202619.03 USD3.6%9.92 USD13.18 USD1.02126.182.2MOn
29 May 202618.36 USD18.6%9.44 USD13.19 USD0.86114.941.9MOn
22 May 202615.48 USD-10.0%9.01 USD13.21 USD0.5991.661.2MOn
15 May 202617.20 USD10.5%8.66 USD13.25 USD0.36120.482.5MOn
8 May 202615.57 USD32.1%8.24 USD13.28 USD0.09103.742.2MOn
1 May 202611.79 USD7.3%7.89 USD13.34 USD-0.2365.34188.7KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.